Chisa Murazawa
7610793, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Status and prognostic value of immunological biomarkers of breast cancer.
Journal: Oncology letters
Published: October 21, 2022
Efficacy of TS-1 as a Late-Line Treatment for Metastatic Breast Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: September 19, 2019
Utility of Prophylactic Administration of Pegfilgrastim in Breast Cancer Chemotherapy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 28, 2018
Candidate biomarkers predictive of anthracycline and taxane efficacy against breast cancer.
Journal: Journal of cancer research and therapeutics
Published: March 09, 2018
Indication of metronomic chemotherapy for metastatic breast cancer: Clinical outcomes and responsive subtypes.
Journal: Molecular and clinical oncology
Published: January 20, 2016
Factors responsible for long-term survival in metastatic breast cancer.
Journal: World journal of surgical oncology
Published: January 30, 2014
Clinical usefulness of human epidermal growth factor receptor-2 extracellular domain as a biomarker for monitoring cancer status and predicting the therapeutic efficacy in breast cancer.
Journal: Cancer biology & therapy
Published: November 02, 2012
Metronomic chemotherapy for metastatic breast cancer to prolong time to treatment failure to 12 months or more.
Journal: Molecular and clinical oncology
Published: July 01, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026